Laddar...
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales
Background: Experience in real clinical practice with ceftazidime-avibactam for the treatment of serious infections due to gram−negative bacteria (GNB) other than carbapenem-resistant Enterobacterales (CRE) is very limited. Methods: We carried out a retrospective multicenter study of patients hospit...
Sparad:
| I publikationen: | Antibiotics (Basel) |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
MDPI
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7168189/ https://ncbi.nlm.nih.gov/pubmed/32050434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics9020071 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|